KRAS and lung adenocarcinoma: A549 (STK11 deficient/KRAS mutant lung adenocarcinoma) cells again demonstrate increased glycolysis and increased HIF1α expression in normoxia, both of which are reduced with either STK11 re-expression or rapamycin treatment16.